Buy & Sell Apellis Pharmaceuticals Inc (APLS) – Apellis Pharmaceuticals Inc Price Today
Key Stats
- $5.25BMarket Cap
- HealthSector
- -0.27%3M Drawdown
- $5.32BEnterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Apellis Pharmaceuticals Inc (APLS) is currently valued at a market capitalization of $5.25B, with an enterprise value of $5.32B. Over the past 52 weeks, Apellis Pharmaceuticals Inc has traded between a low of $16.93 and a high of $41.12, highlighting its annual price range. Over the past three months, Apellis Pharmaceuticals Inc has recorded a drawdown of -0.27%, reflecting recent price volatility. On average, investors hold Apellis Pharmaceuticals Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals is a biopharmaceutical company focused on complement science. It develops therapies for serious diseases, including the first-ever treatment for geographic atrophy, a leading cause of blindness.
Most Recent News
SpaceX IPO sparks investor interest in Rocket Lab as the next big public space launch company.
SpaceX's 2026 IPO on Nasdaq under the ticker SPCX has established a public market benchmark for the space launch economy, prompting investors to seek other investable companies in the sector. Rocket Lab Corporation (Nasdaq: RKLB) stands out with reco...

Gold prices face pressure but long-term bullish outlook remains intact despite recent selloff.
Gold prices have experienced a sharp selloff after reaching record highs, with major support levels breaking down. Short-term forecasts have been downgraded by analysts due to rising U.S. Treasury yields and a stronger dollar, which increase the cost...

Ryanair will let parents sit with kids free after UK regulator probes seating fees.
Ryanair has reversed its policy of charging parents a fee to sit next to their children after the UK's Competition and Markets Authority (CMA) launched an investigation into the practice. Previously, parents paid about $10.70 each way per adult to re...
